Covid-19: Zydus seeks DCGI nod to undertake clinical trials for monoclonal antibodies cocktail

Zydus Cadila on Thursday said it is seeking permission from Drugs Controller General of India (DCGI) to initiate human clinical trials for monoclonal antibodies cocktail for treatment of COVID-19.

from IndiaTV India: Google News Feed https://ift.tt/3yHpXKk

Get Breaking news, Live news, and latest news from India and around the world on INDILIVENEWS.com, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update

Trending News

Loading...